Riccardo Guglielmo

4PUBLICATIONS
26CO-AUTHORS
Clinical psychologyMajor global burdens of diseaseChild and adolescent developmentPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 10, 2026
Functional outcomes with esketamine in treatment-resistant depression: A 6-month multicenter real-world study.

|Mar 24, 2026
Cognitive Effects of Esketamine in Treatment-Resistant Depression: A Systematic Review.

Riccardo Guglielmo, Emma Laura Facchinetti, Daniele Cioci

|Aug 02, 2025
Predictors of Esketamine Response in Treatment-Resistant Depression: The Role of Temperament and Cumulative Treatment Resistance.

Riccardo Guglielmo, Margherita Marino, Elisa Briasco

|Mar 04, 2024
Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force.

Kamilla W Miskowiak, Zacharias K Obel, Riccardo Guglielmo

Pageof 1

Frequent Collaborators

1 joint publications

Kamilla W Miskowiak

1 joint publications

Christopher R Bowie

1 joint publications

Katherine E Burdick

1 joint publications

Andre F Carvalho